Acadia Healthcare’s Strategic Behavioral Health Technology Investments and CTC Expansion to Combat Opioid Use Disorder
Acadia Healthcare (NASDAQ: ACHC), the largest pure-play behavioral health provider in the U.S., is making bold moves this year, focusing heavily on behavioral health...
How Methadone Treatment Access Reform Could Transform Opioid Care in the U.S.
The opioid epidemic continues to devastate communities across America, with millions struggling to access effective treatment. A key part of that treatment is methadone,...
A Dream Realized: Inside the Luxury Residential Treatment Center in Maine That’s Redefining Recovery
At just 11 years old, Tom Rodman made a bold promise to his parents: one day, he would own a summer home on Lake...
The Decline in Buprenorphine Dispensing to Young People: A Closer Look at the Trends, Barriers, and Opportunities for Improvement
Opioid use disorder (OUD) remains a major public health crisis, particularly among young people. Medication-assisted treatment (MAT), which includes buprenorphine, has been recognized as...
Addressing the Urgent Need for Medication-Assisted Treatment for Opioid Use Disorder in Medicare Beneficiaries
The opioid crisis continues to devastate communities across the United States, and while efforts to combat the epidemic have been ongoing, certain populations, particularly...
Financial Integration Isn’t Enough: New Study Questions the Impact of Integrated Managed Care and Behavioral Health Models on Access
In recent years, the push for more integrated health care systems has become a hallmark of Medicaid reform across the United States. The idea...
